The results from current trials of convalescent plasma have not produced a robust result. That does not mean it will be discontinued. To the best of my knowledge, it is not toxic in any way. The people using convalescent plasma in therapies are probably disappointed. They probably expected antibodies to return remarkable results and to date that hasn't happened yet.
Researchers are not going to whitewash results for the sake of politics. There is no deep state here. There is still much a mystery to SARS-CoV-2 and the medical condition it causes called COVID-19.
We know people are producing antibodies from this virus. We do not know the life of those antibodies and whether there is permanent immunity once a person is exposed to SARS-CoV-2 and develops COVID-19. We also know there are cases of people that have contracted the virus and after recovering from the first infection they still get a second one. There are many reasons for these inconsistencies, but, to date, there is still much unknown about this virus.
Once again, the best way to protect against the virus is to social distance, wear masks, and stay at home as much as possible. We know that social venues such as bars and restaurants result in super spreader events. The idea everything is great and going well is not realistic. IT IS A FALSE SENSE OF SAFETY. There were many mistakes made along the way.
This is what is known to be true, the medication remdesivir works. Also, the anti-inflammatory dexamethasone works. It is amazing these two medications are now part of a permanent regime to treat people.
If the other therapies are falling short of expectations it is means we need more investigation to be sure they work, they work well and patients improve directly because the treatment was effective. What is just as important is to know when the therapies didn't work and to find out why.
No one is the deep state or playing politics with American lives from the CDC.
By Tony Hagan
...Although those are largely experimental, (click here) there is sound progress in treatment of late-stage disease, Fauci noted. Two drugs have been shown in placebo-controlled trials to have a beneficial effect in advanced disease. One is the antiviral remdesivir, which has significantly reduced time to recovery and hospital discharge, and the second is dexamethasone, an anti-inflammatory that has reduced the death rate in patients with COVID-19 not yet on ventilators but who need supplementary oxygen. These drugs are already recommended by guidelines-setting authorities for treatment of COVID-19, Fauci said....
